SAGE — Sage Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $544.97m
- $121.11m
- $41.24m
- 36
- 20
- 82
- 43
Annual cashflow statement for Sage Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 606 | -458 | -533 | -541 | -401 |
| Depreciation | |||||
| Non-Cash Items | 95.3 | 94 | 66 | 66.9 | 47.7 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -39.7 | -18.5 | 5.67 | -67.4 | 84.8 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | 664 | -378 | -460 | -541 | -267 |
| Capital Expenditures | -0.345 | -0.372 | -0.937 | -0.553 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 443 | -1,002 | 326 | 443 | 267 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 443 | -1,002 | 325 | 443 | 267 |
| Financing Cash Flow Items | — | -1.39 | -0.043 | -0.903 | -0.52 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 427 | 13.3 | 3.07 | 6.03 | 10.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,534 | -1,367 | -132 | -91.6 | 10.1 |